anmelden
OMX Nordic 40
2.718,06
PKT
+10,11
PKT
+0,37
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 17.01.25 | Volvo (B) Buy | Jefferies & Company Inc. | |
| 16.01.25 | Volvo (B) Neutral | UBS AG | |
| 16.01.25 | Novo Nordisk Buy | UBS AG | |
| 16.01.25 | Ericsson (Telefon L.M.Ericsson) (B) Sell | Goldman Sachs Group Inc. | |
| 16.01.25 | Nokia Sell | Goldman Sachs Group Inc. | |
| 15.01.25 | Volvo (B) Buy | Jefferies & Company Inc. | |
| 15.01.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 15.01.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 14.01.25 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 13.01.25 | Novo Nordisk Buy | UBS AG | |
| 13.01.25 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 13.01.25 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 13.01.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 12.01.25 | Ericsson (Telefon L.M.Ericsson) (B) Underperform | Bernstein Research | |
| 12.01.25 | Nokia Market-Perform | Bernstein Research | |
| 10.01.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 10.01.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 10.01.25 | Volvo (B) Sector Perform | RBC Capital Markets | |
| 10.01.25 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 08.01.25 | Novo Nordisk Buy | UBS AG | |
| 07.01.25 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 07.01.25 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 07.01.25 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 07.01.25 | AstraZeneca Outperform | Bernstein Research | |
| 07.01.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 06.01.25 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 06.01.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 06.01.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 06.01.25 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
| 06.01.25 | ABB (Asea Brown Boveri) Underperform | Bernstein Research | |
| 06.01.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 06.01.25 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 06.01.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 03.01.25 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 02.01.25 | A.P. Moeller - Maersk A-S (B) Underperform | Bernstein Research | |
| 23.12.24 | Novo Nordisk Overweight | Barclays Capital | |
| 23.12.24 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 23.12.24 | Novo Nordisk Halten | DZ BANK | |
| 20.12.24 | Novo Nordisk Underperform | Bernstein Research | |
| 20.12.24 | Novo Nordisk Neutral | UBS AG |
